Skip to main content
FinSpry Logo
FinSpry
OGN logo
OGN
(NYSE)
Organon & Co.
$13.45-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Organon & Co. (OGN) Stock Price & Financial Analysis

Organon & Co. Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.39 - $13.46
52-Week High$13.49
52-Week Low$5.69
Open$13.40
Volume1.53M
Average Volume (3M)3.19M
Market Cap3.52B
Shares Outstanding262.90M
P/E Ratio (TTM)14.32
Forward P/E28.43
Price to Sales (P/S)0.57
Price to Book (P/B)3.90
EV/EBITDA8.46
Revenue (TTM)6.16B
Net Income (TTM)246.00M
Free Cash Flow (TTM)683.00M
EPS (TTM)$0.94
Profit Margin3.99%
Operating Margin18.72%
Return on Equity (ROE)27.24%
Debt to Equity9.49
50-Day MA$12.46
200-Day MA$9.11
52-Week Change37.44%
Annual Dividend$0.08
Dividend Yield0.60%
Payout Ratio8.49%
Last Dividend Ex-DateMay 11, 2026

Frequently Asked Questions About Organon & Co.

What is the current stock price for OGN?

As of the latest trading session, OGN stock trades at $13.45. The 52-week range is $5.69–$13.49, with a day range of $13.39–$13.46.

What is the P/E ratio for OGN?

Organon & Co.'s trailing P/E ratio is 14.3, meaning investors pay $14.3 for every $1 of annual earnings. The forward P/E is 28.4, reflecting analyst expectations for future earnings. Organon & Co. operates in the Healthcare sector.

Does OGN pay dividends?

Yes, Organon & Co. pays a 0.60% annual dividend yield ($0.08 per share). The payout ratio is 8.5%. The last ex-dividend date was 2026-05-11.

What do analysts recommend for OGN?

Based on 5 analysts, the consensus for OGN is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OGN?

Organon & Co.'s market capitalization is $3.54B, classifying it as a mid-cap company. Organon & Co. operates in the Healthcare sector within the Drug Manufacturers - General industry.